The effects of divalent ionophores (A23187 and ionomycin), Ca2+ channel agonist (BAY K 8644), and protein kinase C (C-kinase) activators [phorbol 12-myristate 13-acetate (PMA), mezerein] on bovine tracheal smooth muscle contraction were investigated. A23187 (5 gLM) and ionomycin (0.5 jLM) produced a prompt but transient contraction. Ckinase activators either produced no effect-e.g., PMA at 200 nM-or produced a rise in tension that was slow in onset but then gradually increased-e.g., mezerein at 400 nM. In contrast, ionophores and C-kinase activators, in combination, acted synergistically to produce a prompt and sustained contractile response that is reminiscent of that observed in response to carbachol, a cholinergic agonist. In addition, BAY K 8644 (20 nM), which has a minimal effect on tension by itself, could significantly enhance contraction induced by C-kinase activators. The contraction induced by all of these agents was quickly reversed either by removal of extracellular Ca2" or upon addition of forskolin, an activator of adenylate cyclase. A similar reversal of carbachol-induced contraction by forskolin was observed with carbachol-induced contraction. These rindings strongly suggest that C-kinase plays an important role in mediating tracheal smooth muscle contraction.
Contraction of smooth muscle in response to appropriate agonists is thought to be mediated by an increase in the concentration of intracellular free Ca2". It has been proposed that the critically important Ca2"-mediated step is at the level of the calmodulin-regulated protein kinase, myosin light chain (MLC) kinase (1, 2) . Phosphorylation of the 20-kDa MLC by this enzyme is thought to initiate the interaction between actin and myosin in smooth muscle (1, 2) . Since contraction of smooth muscle in response to agonist is sustained for the period of stimulation, this model implies that both the level of intracellular free Ca2' and the amount of MLC phosphorylated should remain elevated for the duration of agonist action.
Recently, however, Morgan and Morgan have reported that addition of either phenylephrine or angiotensin II to isolated vascular smooth muscle strips leads to an immediate increase in intracellular free Ca2+ concentration, which peaks in 1-3 min and then falls to a value close to the original basal value (3, 4) . However, contraction is sustained even when the intracellular Ca2+ concentration is close to its original basal value (3, 4) . Likewise, the level of phosphorylated MLC in tracheal and vascular smooth muscle reaches a peak within minutes after agonist addition and then falls gradually to near basal values despite the sustained contractile response (5, 6) . These results led to the postulate that a second calciumdependent pathway, other than phosphorylation of MLC, operates during the sustained phase of smooth muscle contraction (5) .
Results from recent work in a variety of secretory systems, including serotonin secretion from platelets (7), prolactin secretion from pituitary cells (8) (9) (10) , insulin secretion from islet cells (11, 12) , aldosterone secretion from adrenal cells (13) (14) (15) , and amylase secretion from pancreatic acinar cells (16) , have led to the development of a model of the calcium messenger system in which there are two branches by which information flows from cell surface to cell interior-(i) a calmodulin branch that is transiently activated by a transient rise in cytosolic free Ca2' and is largely responsible for initiating cellular response and (ii) a protein kinase C (Ckinase) branch that is activated by the transient rise in Ca2+ and an increase in the diacylglycerol content of the plasma membrane and is largely responsible for sustaining the response (17, 18) . Furthermore, a study of the regulation of the sustained phase of aldosterone secretion from adrenal glomerulosa cells suggests that the magnitude of this sustained response is determined by two factors: (i) the amount of activated, Ca2+-sensitive form of C-kinase associated with the plasma membrane and (ii) the rate of Ca2+ cycling across this membrane (15) .
One type of data used to develop this model of calcium messenger system function is that obtained from the use of agents that bypass receptor-mediated events in these tissues and directly activate either the calmodulin-dependent enzymes (e.g., A23187, ionomycin) or the C-kinase enzyme [e.g., phorbol 12-myristate 13-acetate (PMA), mezerein, 1-oleoyl-2-acetyl-glycerol] (6-12, 15, 19) or specifically increase the rate of Ca2+ influx by means of voltage-sensitive channels (e.g., a Ca2+ channel "agonist," BAY K 8644) (20) . In several of the tissues or cells studied, stimulation with A23187 leads to a transient and submaximal secretory response and stimulation with PMA leads to a slowly developing and submaximal response (7) (8) (9) (10) (11) (12) (13) 16) . In contrast, stimulation with the combination of A23187 and PMA leads to a response quantitatively and qualitatively similar to that induced by agonist (7) (8) (9) (10) (11) (12) (13) 16) .
In previous work, an effect of PMA on contraction in vascular smooth muscle was reported (21, 22) . The present study was undertaken to determine whether C-kinase activators (PMA or mezerein), alone or in combination with Ca2+ ionophores (A23187 or ionomycin), would induce contractile responses in bovine tracheal smooth muscle. Having found that these agents, in proper concentrations, induced contractile responses, an additional study was performed in which the effects of BAY K 8644 on PMA-and mezerein-induced contractions were determined. Our results strongly suggest that C-kinase is a second Ca2+-sensitive pathway by which tracheal smooth muscle contraction is regulated.
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MATERIALS AND METHODS
Fresh tracheae from 2-to 4-month-old calves were obtained from a local abbatoir and transported at 00C in (a modified) Tyrode buffer with the following composition: 137 mM NaCl, 11.9 NaHCO3, 5.5 mM dextrose, 0.3 mM NaH2PO4, 2.0 mM KCl, 2.25 mM CaCl2, 1.0 mM MgCl (22, 23) . Trachealis smooth muscle strips were prepared as described by Silver and Stull (6) by dissecting away the intimal and adventitial layers. All dissections were done just prior to use and no tissue older than 2 days was used. Tissue from 2-day-old tracheae responded normally to carbachol. Transverse strips (2-to 3-mm cross-sectional width x 6-to 7-mm length) were mounted vertically in a jacketed muscle bath (36 ± 1C) containing Tyrode buffer aerated with 95% 02/5% CO2. A passive force of 1.5 g was applied to the strips and they were allowed to equilibrate for at least 2 hr. After this period, passive tension was readjusted to about 1.5 g and the strips were challenged with pharmacologic agents when passive tension became stable. When agents other than carbachol were used as stimulant, contraction studies were done in the presence of 0.1 AuM atropine sulfate, which was added 5 min prior to addition of the stimulant. Tension was measured isometrically with Grass FT-03 force-displacement transducers or Statham strain gauges (model UC3) and was displayed on a Gould 2400S recorder with built-in preamplifiers. Since tissue from different sized tracheae exhibited slightly different contractility (as determined by differences in response to carbachol), all comparative studies were done by using strips obtained from the same trachea. Experiments in Ca2+-free medium were done by using Tyrode buffer in which CaCl2 was substituted with 1 mM EGTA.
All drugs were added to the organ bath (10 ml) in volumes not exceeding 10 ,ul. Atropine sulfate (Sigma), diphenhydramine hydrochloride (Sigma), and carbachol (Sigma) were dissolved in H20. PMA (Sigma), mezerein (LC series), and A23187 (Calbiochem-Behring) were dissolved in dimethyl sulfoxide. Ionomycin (Calbiochem-Behring) and forskolin (Calbiochem-Behring) were dissolved in ethanol. BAY K 8644 (Miles) was dissolved in polyethylene glycol to a concentration of 1 nM.
RESULTS
Effects of A23187 and PMA. As is shown in Fig. 1 Upper Left, when tracheal smooth muscle strips were exposed to 5 AM A23187, a prompt contractile response was observed, which peaked in :20 min and then gradually declined with time to a steady-state tension slightly above baseline by 60 min. In most cases, the active tension (i.e., measured tension -basal tension) after 75 min of ionophore stimulation was =30% of peak active tension (Table 1) .
In contrast, no response was observable when muscle strips were exposed to 200 nM PMA for >2 hr ( Fig. 1 Upper Right). Raising the dose of PMA to 500 nM, however, resulted in a very slow and progressive contraction that was observable only after 1-2 hr of drug exposure (results not shown).
The response of muscle strips to simultaneous exposure of A23187 (5 ,M) and PMA (200 nM) was strikingly different from that observed in response to these two drugs individually. There was a prompt contractile response similar or greater in magnitude to that seen with A23187 alone, which was not readily reversed even after 2 hr ( Fig. 1 Lower Left). In repeated trials, the active tension after 75 min of stimulation with A23187 and PMA was twice that observed in strips stimulated with A23187 alone (Table 1) . Thus, there is an apparent synergism between A23187 and PMA in maintaining active tension of tracheal smooth muscle, and the resulting and/or PMA. Fresh bovine tracheal smooth muscle strips were used for each experiment, and strips used here were dissected from the same trachea. All drugs were added at time = 0. In all groups except the carbachol group (Lower Right) , 0.1 ,uM atropine was added 5 min before drug addition.
response is reminiscent of that seen with 0.1 ,uM carbachol stimulation (compare Fig. 1 Lower Left and Lower Right).
Effects of lonomycin and Mezerein. Results similar to that obtained with A23187 and PMA were seen when a different calcium ionophore and C-kinase activator were employed (Fig. 2) . Addition of 0.5 ,uM ionomycin led to a prompt rise in tension that peaked in :20 min and gradually declined to a plateau after 60 min ( Fig. 2 Upper Left). When responses to ionomycin in different strips were averaged, the active tension after 75 and 120 min of exposure to the ionophore was 30% and 34% of the peak active tension, respectively ( Table  1) . Addition of 400 nM mezerein alone led to a slowly developing, progressive, and sustained response that was observable after a 10-to 20-min latency (Fig. 2 Uppet Right). In contrast, combined addition of 0.5 mM ionomycin and 400 nM mezerein led to an initial sharp rise in tension that was followed by a slight fall and then a progressive and sustained response (Fig. 2 Lower Left). In repeated trials, the magnitude of response seen after the combined addition of ionomycin and mezerein was greater, at any point in time, than the sum ofthe responses to the individual stimulant (Fig.  2 Fig. 3 show that the addition of 400 nM mezerein caused a slowly developing response (Fig. 3 Upper Left) and that 20 nM BAY K 8644 led to a slight early response that reached a plateau with time ( Fig. 3 Upper Right). In contrast, addition of 20 nM BAY K 8644 and 400 nM mezerein simultaneously led to a more rapidly developing contraction and greater response than that seen with mezerein alone (Fig. 3 Lower Left). The active tension after 60 and 120 min in response to combined addition of BAY K 8644 and mezerein was greater than the sum of the responses resulting from each of the agents acting independently at these time points (Table 1) (Fig. 4 Upper) or from sequential addition of mezerein and BAY K 8644 (Fig. 4 Lower). The forskolin-induced relaxation in these tissues was very rapid- Similarly, the data in Fig. 5 
DISCUSSION
The present results indicate that tracheal smooth muscle can be induced to contract by agents that activate the C-kinase. The effects of these agents can be blocked by removing extracellular Ca2l (Fig. 5) or enhanced by simultaneous exposure of the muscle to drugs that either stimulate plasma membrane calcium flux and/or raise cytosolic free Ca2+ (Figs. 1-4 (Fig. 3) . In the latter case, the response is completely reversible by removing extracellular Ca2" (Fig. 5 ). Since C-kinase is an enzyme sensitive to diacylglycerol-like activators (e.g., PMA and mezerein) and Ca2+, this synergism in the contractile response suggests the presence of a C-kinase-mediated contractile mechanism in smooth muscle.
It is important to emphasize that although these experiments were done on muscle strips that contain nerve endings and blood cells, it is unlikely that these results can be explained by drug-induced release of neurotransmitter (acetylcholine) or by slow endogenous release of histamineacetylcholine and histamine being two known stimulators of tracheal smooth muscle contraction (24) . All experiments were performed on tissues exposed to 0.1 pM atropine, a dose that has been reported to be sufficient to block the action of neurotransmitter released from nerve endings in response to K+ depolarization in these tissues (6) . Furthermore, when experiments were repeated on tissues exposed to atropine as well as diphenhydramine, an H1 blocker, the responses were Proc. Natl. Acad Sci. USA 82 (1985) ,, qualitatively unchanged, although the magnitude of all responses, including that of the carbachol, was significantly reduced.
Finally, it is noteworthy that the contractile responses induced by various drug combinations were rapidly and completely reversed by addition offorskolin (Fig. 4) , an agent shown to inhibit agonist-induced contractions. Likewise, these responses depend on extracellular Ca2+ (Fig. 5) , analogous to carbachol-induced responses, especially during the sustained phase. The reversibility of these drug-induced contractile responses indicates that they are not a toxic, nonreversible result of the drugs used. In short, these pharmacological agents appear to mimic the postreceptor events involved in smooth muscle contraction by acting directly on the muscle itself. The different contractile responses elicited with agents that increase intracellular Ca2+ versus those that activate C-kinase, the synergism between these two classes of drugs resulting from their combined action on the muscle, as well as the dependency of these responses on extracellular strongly support the idea that receptor-mediated contraction of smooth muscle involves Ca2l action at two different levels: (i) activation of calmodulin-dependent MLC kinase, which is responsible for the initial phase ofthe contractile response, and (ii) activation of C-kinase, which is responsible for the sustained phase of this response (17, 18) . This model is supported by a number of other lines of evidence. First, there is abundant C-kinase in smooth muscle (25) . Second, in several types of smooth muscle, appropriate natural agonist activates the turnover of polyphosphoinositides (25) (26) (27) , giving rise presumably to inositol trisphosphate and diacylglycerol in these tissues as they do in others (28, 29) . Third, addition of inositol trisphosphate to saponin-permeabilized, calcium-loaded smooth muscle cells induces a mobilization of Ca2+ from an ATP-dependent, nonmitochondrial calcium pool (30) as it does in other tissues (14, (31) (32) (33) . These various lines of evidence, previous data obtained from studies on vascular smooth muscle (21) , and the present results all support the concept that the C-kinase branch of the calcium messenger system plays a key role in regulating the sustained phase of tracheal smooth muscle contraction (17) . In this regard, it is noteworthy that the MLC (34), the MLC kinase (35) , and the actin-binding proteins vinculin and filamin (36) are substrates for C-kinase in vitro. It is not yet known whether these proteins become phosphorylated in response to agonist or C-kinase activators in situ.
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